A PARP-1/JNK1 cascade participates in the synergistic apoptotic effect of TNFα and all-trans retinoic acid in APL cells

Oncogene

Volumn 27, Issue 24, 2008, Pages 3361-3370

  Mathieu, J ^a   Flexor, M ^b   Lanotte, M ^a   Besancon F ^a,b  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Apoptosis; ATRA; PARP 1; TNF

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; CYCLOSPORIN A; CYTOCHROME C; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; RETINOIC ACID; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CYTOCHROMES C; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASE 8; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SARCOMA, EWING'S; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44449174535     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210997     Document Type: Article

References (36)

1. Abadie A, Besançon F, Wietzerbin J. (2004). Type I interferon and TNFalpha cooperate with type II interferon for TRAIL induction and triggering of apoptosis in SK-N-MC EWING tumor cells. Oncogene 23: 4911-4920.
2. Adams JM, Corry S. (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337.
3. Adrain C, Creagh EM, Martin SJ. (2001). Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20: 6627-6636.
4. Amran D, Sanchez Y, Fernandez C, Ramos AM, de Blas E, Bréard J et al. (2007). Arsenic trioxide sensitizes promonocytic leukemia cells to TNFα-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways. Biochem Biophys Acta 1173: 1653-16 63.
5. Boulares AH, Zoltoski AJ, Yakovlev A, Xu M, Smulson ME. (2001). Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis. J Biol Chem 276: 38185-3 8192.
6. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666-36 70.
7. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, et al. (2001). Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313.
8. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. (2006). Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25: 6800-6816.
9. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. (2006). Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13: 1423-14 33.
10. Javelaud D, Besançon F. (2001). NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 20: 4365-4372.
11. Javelaud D, Wietzerbin J, Delattre O, Besançon F. (2000). Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells. Oncogene 19: 61-68.
12. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661.
13. Kukekov NV, Xu Z, Greene LA. (2006). Direct interaction of the molecular scaffolds POSH and JIP is required for apoptotic activation of JNKs. J Biol Chem 281: 15517-15524.
14. Laine A, Ronai Z. (2005). Ubiquitin chains in the ladder of MAPK signaling. Sci STKE 281: re5.
15. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. (1991). NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-10 86.
16. Lejeune FJ, Rüegg C. (2006). Recombinant human tumor necrosis factor: an efficient agent for cancer treatment. Bull Cancer 93: 90-100.
17. Locksley RM, Killeen N, Lenardo MJ. (2001). The TNF and TNF receptor superfamilies: integratin g mammalian biology. Cell 104: 487-501.
18. Manna SK, Aggarwal BB. (2000). All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells. Oncogene 19: 2110-2119.
19. Mathieu J, Besançon F. (2006). Clinically tolerable concentrations of arsenic trioxide induce p53-independent cell death and repress NF-kappa B activation in Ewing sarcoma cell. Int J Cancer 119: 1723-1727.
20. Mathieu J, Giraudier S, Lanotte M, Besançon F. (2005). Retinoid-induced activation of NF-kappaB in APL cells is not essential for granulocytic differentiation, but prolongs the life span of mature cells. Oncogene 24: 7145-71 55.
21. Micheau O, Tschopp J. (2003). Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190.
22. Nakamura J, Asakura S, Hester SD, de Murcia G, Caldecott KW, Swenberg JA. (2003). Quantitation of intracellular NAD(P)H can monitor an imbalance of DNA single strand break repair in base excision repair deficient cells in real time. Nucleic Acids Res 31: 1-7.
23. Nguewa PA, Fuertes MA, Alonso C, Perez JM. (2003). Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitat ion in cancer chemotherapy. Mol Pharmacol 64: 1007-1014.
24. Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ. (1998). Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 4: 408-414.
25. Schreiber V, Dantzer F, Ame JC, de Murcia G. (2006). Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517-528.
26. Suk K, Chang I, Kim YH, Kim S, Kim JY, Kim H et al. (2001). Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J Biol Chem 276 13153-13159.
27. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M et al. (2001). Inhibition of JNK activation through NF-kappaB target genes. Nature 414: 313-317.
28. Tobler A, Munker R, Heitjan D, Koeffler HP. (1987). In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells. Blood 70: 1940-1946.
29. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. (1995). Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 14: 2876-2883.
30. Van Horssen R, Ten Hagen TL, Eggermont AM. (2006). TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11: 397-408.
31. Van Molle W, Wielockx B, Mahieu T, Takada M, Taniguchi T, Sekikawa K et al. (2002). HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16: 685-695.
32. Weston CR, Davis RJ. (2007). The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149.
33. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ. (1998). A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674.
34. Witcher M, Ross DT, Rousseau C, Deluca L, Miller Jr WH. (2003). Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood 102: 237-245.
35. Xu Y, Huang S, Liu ZG, Han J. (2006). Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 281: 8788-87 95.
36. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ et al. (2002). Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263.